Generic Name and Formulations:
Sulfanilamide 15%; vaginal crm.
Indications for AVC:
Vulvovaginitis caused by Candida albicans.
1 applicatorful vaginally 1–2 times daily for 30 days.
Discontinue if severe or unusual irritation occurs. Avoid using vaginal applicator after 7th month of pregnancy. Pregnancy (Cat.C). Nursing mother: not recommended.
Crm—4oz (w. applicator)
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL